G. Bruce  Papesh net worth and biography

G. Papesh Biography and Net Worth

Director of Neogen
G. Bruce Papesh serves as Independent Director of the Company. Mr. Papesh was elected to the Board in October 1993 and was the Company’s Secretary from October 1994 to October 1999. Since 1987, Mr. Papesh has served as President of Dart, Papesh & Company, Inc., member of SIPC and FINRA, an investment consulting and financial services firm. Mr. Papesh also served until October 1, 2001 on the board of directors of Immucor, Inc., an immunodiagnostics company that manufactures and markets products for the human clinical blood bank industry. Mr. Papesh has experience in the investment securities industry and in financial analysis which contributes greatly to the Board.

What is G. Bruce Papesh's net worth?

The estimated net worth of G. Bruce Papesh is at least $606,733.27 as of March 25th, 2021. Mr. Papesh owns 40,261 shares of Neogen stock worth more than $606,733 as of March 18th. This net worth estimate does not reflect any other assets that Mr. Papesh may own. Learn More about G. Bruce Papesh's net worth.

How do I contact G. Bruce Papesh?

The corporate mailing address for Mr. Papesh and other Neogen executives is 620 LESHER PLACE, LANSING MI, 48912. Neogen can also be reached via phone at (517) 372-9200 and via email at [email protected]. Learn More on G. Bruce Papesh's contact information.

Has G. Bruce Papesh been buying or selling shares of Neogen?

G. Bruce Papesh has not been actively trading shares of Neogen during the last ninety days. Most recently, Bruce Papesh sold 7,000 shares of the business's stock in a transaction on Thursday, March 25th. The shares were sold at an average price of $85.42, for a transaction totalling $597,940.00. Following the completion of the sale, the director now directly owns 40,261 shares of the company's stock, valued at $3,439,094.62. Learn More on G. Bruce Papesh's trading history.

Who are Neogen's active insiders?

Neogen's insider roster includes John Adent (CEO), William Boehm (Director), Ronald Green (Director), Douglas Jones (Insider), Jason Lilly (VP), Terri Morrical (Director), David Naemura (CFO), G. Papesh (Director), Steven Quinlan (CFO), James Tobin (Director), and Darci Vetter (Director). Learn More on Neogen's active insiders.

Are insiders buying or selling shares of Neogen?

In the last twelve months, Neogen insiders bought shares 3 times. They purchased a total of 22,000 shares worth more than $334,100.00. In the last twelve months, insiders at the sold shares 4 times. They sold a total of 6,359 shares worth more than $109,708.34. The most recent insider tranaction occured on November, 3rd when Director William T Boehm bought 2,000 shares worth more than $32,100.00. Insiders at Neogen own 0.7% of the company. Learn More about insider trades at Neogen.

Information on this page was last updated on 11/3/2023.

G. Bruce Papesh Insider Trading History at Neogen

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
3/25/2021Sell7,000$85.42$597,940.0040,261View SEC Filing Icon  
1/13/2021Sell30,000$83.40$2,502,000.0042,261View SEC Filing Icon  
See Full Table

G. Bruce Papesh Buying and Selling Activity at Neogen

This chart shows Bruce Papesh's buying and selling at Neogen by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Neogen Company Overview

Neogen logo
Neogen Corporation, together with its subsidiaries, engages in the development, manufacture, and marketing of various products and services dedicated to food and animal safety worldwide. It operates through two segments, Food Safety and Animal Safety. The Food Safety segment offers diagnostic test kits and related products to detect dangerous and unintended substances in food and animal feed, including foodborne pathogens, spoilage organisms, natural toxins, food allergens, genetic modifications, ruminant by-products, meat speciation, drug residues, pesticide residues, and general sanitation concerns; and AccuPoint Advanced rapid sanitation test to detect the presence of adenosine triphosphate, a chemical found in living cells, as well as provides genomics-based diagnostic technology and software systems that help testers to objectively analyze and store their results and perform analysis on the results from multiple locations over extended periods. The segment offers its products primarily to milling and grain, meat and poultry, prepared foods and ingredients, fruits and vegetables, seafood, dairy, beverage, water, healthcare, traditional culture media markets, food service, and dietary supplements markets. The Animal Safety segment provides veterinary instruments, pharmaceuticals, vaccines, topicals, parasiticides, diagnostic products, rodent control products, cleaners, disinfectants, insect control products, and genomics testing services marketed through veterinarians, retailers, livestock producers, and animal health product distributors, for the animal safety market. The segment offers its products for companion animal veterinarians; livestock producers, veterinarians, and breed associations; retailers; breeding and genetics companies; diagnostic labs and universities; distributors; and other manufacturers and government agencies. Neogen Corporation was incorporated in 1981 and is headquartered in Lansing, Michigan.
Read More

Today's Range

Now: $15.07
Low: $15.04
High: $15.27

50 Day Range

MA: $16.81
Low: $15.06
High: $19.84

2 Week Range

Now: $15.07
Low: $14.44
High: $24.09

Volume

1,287,266 shs

Average Volume

1,972,509 shs

Market Capitalization

$3.26 billion

P/E Ratio

251.21

Dividend Yield

N/A

Beta

1.14